Skip to main content

Euclidean Capital LLC

Location
NEW YORK, NY
Portfolio Value
Small $439,833,129
Diversification
Highly concentrated
Filing Date
Global Rank
#4,166 / 8,794 ▼ 235 · as of Jun 2026
Top Industry
Biotechnology 75.3%
Period ended 3 months ago
Filed Aug 14, 2026 · 52d
23 quarters · since Dec 2020

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

10 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026
Top Position
61.8%
−3.2 pts
Top 5
96.2%
−2.2 pts
Top 10
100.0%
0.0 pts
HHI
4,510
Sep 2023 → Jun 2026 · range 4,127 – 9,099
Highly concentrated−467

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026
Sector % Portfolio Value
Unclassified 91.7% $403,219,929
Healthcare 6.3% $27,571,414
Financial Services 2.1% $9,041,786

Last Quarter's Activity

Export CSV
Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased
No qualifying positions this quarter.

Trimmed

Positions the filer reduced
No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter
1 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
No qualifying positions this quarter.

Portfolio Positions

Export CSV View 13F filing
10 tracked positions · $439,833,129 total · filing declares 11 positions · $439,836,054 · as of Jun 30, 2026
Ticker Company Shares Value (USD) % of Portfolio History

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.